Abstract
The aetiology and pathogenesis of scleroderma is incompletely understood. Recently, a cell called the fibrocyte has been shown to be derived from circulating monocytes with the ability to produce collagen. The aim of this study was to evaluate differences in the cell surface characteristics of circulating fibrocyte progenitors (monocytes) in patients with limited scleroderma compared to controls. A case-control study was performed in eight patients with limited scleroderma, which were matched with eight controls. Three-colour flow cytometry was used to assess the relative expression of cell surface markers. Statistical analysis then compared the relative expression between the two groups. In this preliminary study, there were no significant differences in the expression of circulating monocyte surface molecules involved with cell transformation, function, or migration presumed to give rise to fibrocytes, in a population of patients with limited scleroderma. Various explanations for the results are discussed.
This is a preview of subscription content, log in via an institution to check access.
References
LeRoy EC, Black C, Fleishmajer R et al (1998) Scleroderma (systemic sclerosis): classification, subsets, and pathogenesis. J Rheumatol 15:202–205
Douvas A (1996) Pathogenesis: serologic correlates. In: Clements PJ, Furst DE (eds) Systemic sclerosis. Williams and Wilkins, Baltimore, pp 175–202
White B (1996) Pathogenesis: serologic correlates. In: Clements PJ, Furst DE (eds) Systemic sclerosis. Williams and Wilkins, Baltimore, pp 229–250
LeRoy EC, McGuire M, Chen N (1974) Increased collagen synthesis by scleroderma fibroblasts in vitro. A possible defect in the regulation or activation of the scleroderma fibroblast. J Clin Invest 54:880–889
Bucala R, Spiegal LA, Chesney J, Hogan M, Cerami A (1994) Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1:71
Abe R, Donnelly S, Peng T, Bucala R, Metz C (2001) Peropheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 166:7556–7562
Aiba S, Tabata N, Ohtani H, Tagami H (1994) CD34+ spindle-shaped cells selectively disappear from the skin lesions of scleroderma. Arch Dermatol 130:593–597
The Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590
Hauser C, Kaya G, Chizzolini C (2004) Nephrogenic fibrosing dermopathy in a renal transplant recipient with tubulointerstitial nephritis and uveitis. Dermatology 209:50–52
Cowper S, Su L, Bhawan J, Robin H, LeBoit PE (2001) Nephrogenic fibrosing dermopathy. Am J Dermatopathol 23(5):383–393
Pilling D, Buckley CD, Salmon M, Gomer R (2003) Inhibition of fibrocyte differentiation by serum Amyloid P. J Immunol 171(10):5537–5546
Acknowledgments
We are grateful to Prof. J. Fletcher, Dr. G. Howe and Dr. D. Spencer for helpful discussions.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Russo, R., Medbury, H., Guiffre, A. et al. Lack of increased expression of cell surface markers for circulating fibrocyte progenitors in limited scleroderma. Clin Rheumatol 26, 1136–1141 (2007). https://doi.org/10.1007/s10067-006-0461-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-006-0461-5